Laurence Weiss

Summary

Country: France

Publications

  1. ncbi request reprint Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy
    L Weiss
    Service d immunologie clinique, Université Pierre et Marie Curie and Institut National de la Santé et de la Recherche Médicale INSERM U430, Hopital Europeen Georges Pompidou, Paris, France
    HIV Med 3:12-20. 2002
  2. ncbi request reprint [Immune-based therapies and HIV infection]
    Laurence Weiss
    Service d Immunologie Clinique et INSERM U 430, Hopital Europeen Georges Pompidou, Universite Pierre et Marie Curie, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Ann Med Interne (Paris) 153:227-36. 2002
  3. doi request reprint Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy
    Charlotte Charpentier
    Laboratoire de Virologie, Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France
    Scand J Infect Dis 43:373-9. 2011
  4. ncbi request reprint Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by
    Cedric Carbonneil
    Institut National de la Santé et de la Recherche Médicale Unité 430, Institut des Cordeliers, Paris, France
    J Immunol 172:7832-40. 2004
  5. doi request reprint Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients
    Charlotte Charpentier
    Laboratoire de Virologie, AP HP, Hopital Europeen Georges Pompidou, Paris, France Université Paris Descartes, Faculte de Medecine, Paris, France
    J Clin Virol 43:212-5. 2008
  6. pmc Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
    Laurence Weiss
    Faculte de Medecine, Universite Paris Descartes, Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Paris, France
    PLoS ONE 5:e11659. 2010
  7. doi request reprint High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors
    Charlotte Charpentier
    Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Laboratoire de Virologie, France
    AIDS 24:867-73. 2010
  8. doi request reprint Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure
    Sophie Stegmann
    Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Service d immunologie clinique, Paris, France
    J Clin Virol 47:79-81. 2010
  9. pmc The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation
    Mathieu F Chevalier
    Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France
    PLoS Pathog 9:e1003453. 2013
  10. ncbi request reprint Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy
    Jeanne Serpaggi
    Hepatology Unit, Necker Hospital, Paris, France
    AIDS 20:233-40. 2006

Detail Information

Publications47

  1. ncbi request reprint Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy
    L Weiss
    Service d immunologie clinique, Université Pierre et Marie Curie and Institut National de la Santé et de la Recherche Médicale INSERM U430, Hopital Europeen Georges Pompidou, Paris, France
    HIV Med 3:12-20. 2002
    ..To investigate the extent of functional T cell recovery and to characterize plasma virus and virus producing cells in patients with increasing CD4 cell counts despite virological failure during protease inhibitor (PI) based therapy...
  2. ncbi request reprint [Immune-based therapies and HIV infection]
    Laurence Weiss
    Service d Immunologie Clinique et INSERM U 430, Hopital Europeen Georges Pompidou, Universite Pierre et Marie Curie, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Ann Med Interne (Paris) 153:227-36. 2002
    ..Participation of immune system to control of viral replication may allow simplification of antiretroviral treatment which results in long-term adverse effects having impact in life quality of persons living with HIV...
  3. doi request reprint Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy
    Charlotte Charpentier
    Laboratoire de Virologie, Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France
    Scand J Infect Dis 43:373-9. 2011
    ....
  4. ncbi request reprint Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by
    Cedric Carbonneil
    Institut National de la Santé et de la Recherche Médicale Unité 430, Institut des Cordeliers, Paris, France
    J Immunol 172:7832-40. 2004
    ..Taken together, our results indicate that IFN-DCs are more efficient than IL-4-DCs to stimulate CD4(+) T cell proliferation, further supporting their use for immune-based therapy in HIV infection...
  5. doi request reprint Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients
    Charlotte Charpentier
    Laboratoire de Virologie, AP HP, Hopital Europeen Georges Pompidou, Paris, France Université Paris Descartes, Faculte de Medecine, Paris, France
    J Clin Virol 43:212-5. 2008
    ..Salvage therapy based on foscarnet plus a thymidine analog is effective in patients with advanced-stage HIV disease and viruses harbouring multiple drug-resistance mutations...
  6. pmc Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
    Laurence Weiss
    Faculte de Medecine, Universite Paris Descartes, Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Paris, France
    PLoS ONE 5:e11659. 2010
    ..However, the insufficient increase in the proportion and/or the decrease in the absolute number of Tregs result in a failure to control immune activation following TI...
  7. doi request reprint High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors
    Charlotte Charpentier
    Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Laboratoire de Virologie, France
    AIDS 24:867-73. 2010
    ..Integrase positions 148 and 155 represent main determinants of resistance to integrase inhibitors. We assessed the prevalence of minority variants harboring such mutations in integrase-naive HIV-infected patients...
  8. doi request reprint Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure
    Sophie Stegmann
    Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Service d immunologie clinique, Paris, France
    J Clin Virol 47:79-81. 2010
    ..Four months after the end of foscarnet therapy, HIV-2 plasma viral load remained undetectable. This case report suggests that foscarnet may represent a therapeutic option for HIV-2-infected patients exhibiting multidrug resistance...
  9. pmc The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation
    Mathieu F Chevalier
    Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France
    PLoS Pathog 9:e1003453. 2013
    ..Moreover, the "innate immune set point" defined by the early levels of sCD14 and IL-1RA might be powerful early surrogate markers for disease progression and should be considered for use in clinical practice. ..
  10. ncbi request reprint Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy
    Jeanne Serpaggi
    Hepatology Unit, Necker Hospital, Paris, France
    AIDS 20:233-40. 2006
    ....
  11. doi request reprint A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Paris, France
    J Med Virol 82:1819-28. 2010
    ..A high PBMC HIV DNA level at TI was a strong predictor for more rapid treatment resumption...
  12. ncbi request reprint Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection
    Sophie Grabar
    INSERM U720, Faculté de Médecine Pitié Salpêtrière, Universite Paris VI, and Service de Biostatistique et Informatique Médicale, Hopital Cochin, Universite Paris V, Paris, France
    J Acquir Immune Defic Syndr 39:284-92. 2005
    ..To compare the long-term prognostic significance of different definitions of immunologic and virologic responses to highly active antiretroviral therapy (HAART) at 6 months...
  13. doi request reprint Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005
    Valerie Potard
    UPMC Univ Paris 06, UMR_S 943, Paris, France
    J Acquir Immune Defic Syndr 52:422-6. 2009
    ..We studied trends in initial post infection CD4 cell counts and viral load values in patients diagnosed at estimated time of primary infection between 1997 and 2005 in France...
  14. doi request reprint The split personality of regulatory T cells in HIV infection
    Mathieu F Chevalier
    Institut Pasteur, Departement de Virologie, Régulation des Infections Rétrovirales, Paris, France
    Blood 121:29-37. 2013
    ..Results must be interpreted with regard to both the Treg definition used in context and to the setting of the disease in an attempt to draw clearer conclusions from the apparently conflicting results...
  15. doi request reprint A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control
    Lambert Assoumou
    aSorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d Epidémiologie et de Santé Publique bUMR_S 1136, Institut Pierre Louis d Epidémiologie et de Santé Publique cAP HP Hôpital Européen Georges Pompidou dUniversité Paris Descartes Sorbonne Paris Cité eLaboratoire de Virologie, AP HP Hôpital Necker fEA 7327 Université Paris Descartes Sorbonne Paris Cité gAP HP Hôpital Saint Antoine, Paris, France
    AIDS 29:2003-7. 2015
    ....
  16. doi request reprint Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART
    Christophe Piketty
    AP HP Service d Immunologie Clinique, Hopital Europeen Georges Pompidou, France
    AIDS 27:401-6. 2013
    ..The impact of cART on the natural history of HPV infection and ASIL is poorly documented...
  17. doi request reprint Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial
    Nathalie de Castro
    Department of Infectious Diseases, Assistance Publique Hopitaux de Paris, Saint Louis Hospital and University of Paris VII Denis Diderot, Paris, France
    Clin Infect Dis 49:1259-67. 2009
    ..We conducted a prospective, randomized, open-label trial to compare the antiviral efficacy and safety of a switch to raltegravir with the efficacy and safety of continuing enfuvirtide...
  18. doi request reprint Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy
    Laurence Weiss
    AP HP Hôpital Européen Georges Pompidou, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France Currently Urology Research Unit, Lausanne University Hospital, Lausanne, Switzerland Sorbonne Universités, Institut Pierre Louis d Epidémiologie et de Santé Publique, Paris, France INSERM, Institut Pierre Louis d Epidémiologie et de Santé Publique, Paris, France Lip Sys 2, Faculte de Pharmacie, Universite Paris Sud, Chatenay Malabry, France Service de Biochimie, and Laboratoire d Hématologie, AP HP, Hopital Europeen Georges Pompidou, Paris, France and AP HP Hôpital Saint Antoine, Paris, France
    J Acquir Immune Defic Syndr 71:390-8. 2016
    ....
  19. ncbi request reprint Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
    Cedric Carbonneil
    INSERM U430, Institut des Cordeliers, Paris, France
    Int Immunol 16:1037-52. 2004
    ....
  20. doi request reprint Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV
    Yves Levy
    INSERM, Unité U, Groupe Henri Mondor Albert Chenevier, Service d immunologie clinique, Creteil, France
    AIDS 26:711-20. 2012
    ..Interleukin (IL)-2 therapy impacts T-cell homeostasis. Whether IL-2 expanded CD4(+) T cells may persist following viral rebound has not been fully investigated...
  21. doi request reprint Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection
    Gael Petitjean
    Institut Pasteur, Régulation des Infections Rétrovirales, Departement de Virologie, Paris, France
    AIDS 26:139-48. 2012
    ..The aim of this study was to analyze, in patients with primary HIV infection (PHI), the relationship between CD4(+)CD25(+)CD127(low)FoxP3(+) nTregs or CD3(+)CD4(-)CD8(-) double negative T cells and systemic immune activation...
  22. ncbi request reprint Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients
    Jean Paul Duong Van Huyen
    Department of Pathology, Hopital Europeen Georges Pompidou, université Paris V René Descartes, Paris, France
    Mod Pathol 19:1277-88. 2006
    ..The results of the study suggest that COX subunit I labeling may be a valuable tool for the diagnosis of mitochondrial liver disease in HIV patients...
  23. pmc CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden
    Mathieu F Chevalier
    Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France
    Front Immunol 7:395. 2016
    ..Moreover, our data also suggest a benefit of early treatment for the maintenance of HIV-specific CD4 T-cell help...
  24. doi request reprint A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients
    Marion Bouillon-Pichault
    Universite Paris Descartes, Paris, France
    Antivir Ther 14:923-9. 2009
    ..However, the probability to achieve these target C(troughs) with the current 400 mg twice-daily or 800 mg once-daily doses of the new tablet form, and the influence of body weight on this probability are unknown...
  25. ncbi request reprint Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene
    Ali Si-Mohamed
    Laboratoire de Virologie, Hopital Europeen Georges Pompidou, Paris, France
    J Acquir Immune Defic Syndr 44:1-5. 2007
    ..Sequence variations in HR-1 gp41 env gene region encoding the target for T-20 have previously been reported among patients naive to inhibitory fusion...
  26. ncbi request reprint HIV infection in older patients in the HAART era
    Sophie Grabar
    Service de Biostatistique et Informatique Médicale, Universite Paris Descartes, Faculte de Medecine, Hopital Cochin, Paris, France
    J Antimicrob Chemother 57:4-7. 2006
    ..Information campaigns targeting older patients and their doctors are also needed to ensure timely diagnosis of HIV infection and antiretroviral treatment initiation...
  27. ncbi request reprint Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients
    Laurence Weiss
    Institut National de la Santé et de la Recherche Médicale U430, University of Paris V, France
    Blood 104:3249-56. 2004
    ..Taken together, our results suggest that persistence of HIV antigens might trigger the expansion of CD4(+)CD25(+) regulatory T cells, which might induce a tolerance to HIV in vivo...
  28. ncbi request reprint Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases
    Marie Agnès Dragon-Durey
    INSERM U430, Institut des Cordeliers, Paris, France
    J Am Soc Nephrol 15:787-95. 2004
    ..This report emphasizes the variability in the clinical progression of kidney diseases associated with FH deficiencies. Genetic analysis reveals the molecular abnormalities associated with FH deficiencies to be polymorphous...
  29. ncbi request reprint Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2
    Veronique Fremeaux-Bacchi
    Departement d Immunologie, Hopital Europeen Georges Pompidou, Paris, France
    Am J Med 113:194-9. 2002
    ..We studied the clinical features, complement profiles, and associated diseases in 19 new patients with diagnosed acquired angioedema type 2...
  30. doi request reprint Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study
    Bernard Mole
    APHP, Service d immunologie clinique, Hopital Europeen Georges Pompidou, Paris, France
    AIDS Res Hum Retroviruses 28:251-8. 2012
    ..Polyacrylamide hydrogel injections were well tolerated and significantly improved the aesthetic aspect and quality of life of HIV-infected patients with facial lipoatrophy...
  31. ncbi request reprint Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells
    Cedric Carbonneil
    INSERM U430, Paris, France
    AIDS 17:1731-40. 2003
    ....
  32. ncbi request reprint Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy
    Jean Paul Duong Van Huyen
    Department of Pathology, European Georges Pomoidou Hospital, INSEM U430, Broussais Hospital, Paris, France
    Am J Clin Pathol 119:546-55. 2003
    ....
  33. pmc Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study
    Matthieu Lafaurie
    Department of Infectious Diseases, Saint Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France
    PLoS ONE 9:e112836. 2014
    ..Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis have not been fully investigated...
  34. pmc CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
    Dominique Costagliola
    INSERM and Sorbonne Universités, UPMC Paris Univ 06, Pierre Louis Institute, UMR S 1136, Paris, France
    J Int AIDS Soc 17:19481. 2014
    ..However, a high proportion of patients present late for care. Our objective was to assess CD4 cell count recovery up to seven years in naïve patients initiating cART with at least three drugs in usual clinical care...
  35. ncbi request reprint Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review
    Mustapha Sodqi
    Department of Immunology, European Hospital Georges Pompidou, Paris, France
    Scand J Infect Dis 36:230-1. 2004
    ..We report here the fifth case of pulmonary localization of E. bieneusi in a severe immunocompromized HIV-infected patient with intestinal and pulmonary symptoms...
  36. pmc Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
    Charlotte Charpentier
    Assistance Publique Hopitaux de Paris, Hopital Bichat Claude Bernard, Laboratoire de Virologie, Universite Paris Diderot, Paris, France
    Infect Drug Resist 3:103-14. 2010
    ..In conclusion, raltegravir improved the clinical management of HIV-1 infection both in antiretroviral-naïve and in antiretroviral-experienced patients...
  37. ncbi request reprint Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome
    Marie Agnès Dragon-Durey
    Service d Immunologie Biologique, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France
    J Am Soc Nephrol 16:555-63. 2005
    ..This new mechanism of functional FH deficiency may lead to the design of new approaches of diagnosis and treatment with a particular interest in plasma exchanges or immunosuppressive therapies...
  38. ncbi request reprint Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa
    Dominique Batisse
    Service d immunologie clinique, Hopital Europeen Georges Pompidou, Paris, France
    Eur J Gastroenterol Hepatol 16:701-3. 2004
    ..The long half-life of peginterferon might explain the long-lasting symptoms of vasculitis. Clinicians should be aware of possible sustained flare of cryoglobulinaemia-associated vasculitis in patients receiving peginterferon...
  39. doi request reprint Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir
    B Masquelier
    Laboratoire de Virologie, CHU de Bordeaux and EA 2968, Universite Victor Segalen, Bordeaux, France
    J Antimicrob Chemother 61:1362-8. 2008
    ..We developed clinically relevant genotypic scores for resistance to fosamprenavir/ritonavir in HIV-1 protease inhibitor (PI)-experienced patients...
  40. ncbi request reprint Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2
    Zoe Fox
    Hvidovre University Hospital, DK 2650 Hvidovre, Denmark
    HIV Med 8:112-23. 2007
    ..The IL-2 induction phase consists of three dosing cycles over 6-8 months (7.5 MIU twice a day, for 5 days every 8 weeks)...
  41. ncbi request reprint Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials)
    Christine Durier
    INSERM SC10, Villejuif, France
    AIDS 21:1887-97. 2007
    ..Interleukin (IL)-2 therapy leads to significant CD4 cell increases in HIV-infected patients. Since phase III trials are ongoing, studies supporting the long-term feasibility of this strategy are needed...
  42. pmc Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames
    Sylvain Cardinaud
    Unité Cellulaire Antivirale, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France
    J Exp Med 199:1053-63. 2004
    ..This should be taken into account when designing vaccine strategies aimed at activating these responses...
  43. ncbi request reprint Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial
    Yves Levy
    Unit of Clinical Immunology, Hospital Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010 Creteil Cedex, France
    AIDS 17:343-51. 2003
    ..Intermittent interleukin-2 (IL-2) therapy leads to a sustained increase of CD4 T cells in HIV-1-infected patients...
  44. ncbi request reprint Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study
    Serge Diagbouga
    Centre Muraz, Bobo Dioulasso, Burkina Faso
    AIDS 17:2201-8. 2003
    ....
  45. ncbi request reprint Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene
    Laurent Andreoletti
    J Acquir Immune Defic Syndr 29:102-4. 2002
  46. ncbi request reprint Recurring acute abdominal pains in an adolescent as the presenting manifestations of hereditary angioneurotic oedema
    Laurence Foix-L'Hélias
    Department of Paediatrics, Antoine Béclère Teaching Hospital, 92141 Clamart Cedex, France
    Acta Paediatr 94:1158-61. 2005
    ..Laboratory data finally led to the diagnosis of hereditary angioneurotic oedema, after several hypotheses had been raised and ruled out...
  47. doi request reprint Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry
    Thomas Le Saux
    Universite Paris Descartes, Faculte de Medecine, Service de Pharmacologie Clinique, Groupe Hospitalier Cochin Saint Vincent De Paul, Assistance Publique, Hopitaux de Paris, France
    J Chromatogr B Analyt Technol Biomed Life Sci 865:81-90. 2008
    ..The method has been implemented to assess plasma concentrations of patients infected by HIV and was found suitable for therapeutic drug monitoring...